This provider's $18.0M in total Medicare payments ranks in the 99th percentile of Diagnostic Radiology providers nationally.
Medicare payments to this provider grew 64% from 2014 to 2023.
71% of their billing comes from a single procedure code (78815 — Nuclear medicine study with CT imaging skull base to mid-thigh).
AI-generated analysis based on Medicare payment data.
Average per-service amounts submitted by the provider compared to what Medicare actually paid — the gap represents the markup.
| Year | Avg Submitted | Avg Paid | Markup Ratio | Gap per Service | Total Payments | Services | Beneficiaries |
|---|---|---|---|---|---|---|---|
| 2014 | $420.02 | $157.51 | 2.67x | $262.51 | $1.3M | 4.9K | 4.7K |
| 2015 | $418.23 | $157.13 | 2.66x | $261.10 | $1.2M | 4.8K | 4.6K |
| 2016 | $526.62 | $226.22 | 2.33x | $300.40 | $1.4M | 4.4K | 4.3K |
| 2017 | $623.71 | $265.67 | 2.35x | $358.04 | $1.8M | 5.3K | 5.0K |
| 2018 | $717.26 | $266.55 | 2.69x | $450.71 | $1.9M | 5.7K | 5.5K |
| 2019 | $685.11 | $270.31 | 2.53x | $414.80 | $2.0M | 5.9K | 5.7K |
| 2020 | $621.07 | $225.27 | 2.76x | $395.80 | $1.8M | 4.6K | 4.3K |
| 2021 | $852.72 | $388.42 | 2.20x | $464.30 | $2.1M | 4.9K | 4.6K |
| 2022 | $648.02 | $239.78 | 2.70x | $408.24 | $2.3M | 4.5K | 4.2K |
| 2023 | $765.51 | $271.05 | 2.82x | $494.46 | $2.2M | 4.2K | 4.0K |
| Code | Description | Services | Payments | Avg/Service | Markup |
|---|---|---|---|---|---|
| 78815 | Nuclear medicine study with CT imaging skull base to mid-thigh | 11.6K | $12.4M | $1.1K | 2.50x |
| 78816 | Nuclear medicine study with CT imaging whole body | 948 | $1.1M | $1.2K | 2.50x |
| A9552 | Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries | 9.3K | $693.1K | $74.26 | 6.55x |
| 78306 | Bone and/or joint imaging, whole body | 2.8K | $627.6K | $225.34 | 2.66x |
| 78452 | Nuclear medicine study of vessels of heart using drugs or exercise multiple studies | 6.9K | $429.8K | $62.07 | 4.02x |
| 78315 | Bone and/or joint imaging, 3 phase study | 1.5K | $427.9K | $282.05 | 2.47x |
| A9588 | Fluciclovine f-18, diagnostic, 1 millicurie | 90 | $242.0K | $2.7K | 1.40x |
| 78227 | Imaging of liver and bile duct system with use of drugs | 1.2K | $241.9K | $197.95 | 2.89x |
| A9595 | Piflufolastat f-18, diagnostic, 1 millicurie | 321 | $234.2K | $729.66 | 1.40x |
| 78264 | Stomach emptying study | 891 | $232.0K | $260.38 | 2.44x |
| 78582 | Nuclear medicine study of lung ventilation and blood circulation in the lungs | 1.6K | $150.6K | $96.49 | 3.25x |
| A9562 | Technetium tc-99m mertiatide, diagnostic, per study dose, up to 15 millicuries | 431 | $114.9K | $266.62 | 3.84x |
| 78226 | Imaging of liver and bile duct system | 653 | $113.0K | $173.01 | 3.04x |
| A9503 | Technetium tc-99m medronate, diagnostic, per study dose, up to 30 millicuries | 3.1K | $90.4K | $28.96 | 1.51x |
| 78708 | Nuclear medicine study of kidney with assessment of blood flow and function | 589 | $82.7K | $140.36 | 3.43x |
| 78071 | Imaging of parathyroid with nuclear medicine study | 252 | $76.0K | $301.62 | 3.55x |
| A9586 | Florbetapir f18, diagnostic, per study dose, up to 10 millicuries | 34 | $73.2K | $2.2K | 1.35x |
| 78814 | Nuclear medicine study with CT imaging | 92 | $71.8K | $780.21 | 2.67x |
| 78014 | Nuclear medicine imaging for thyroid uptake measurements | 342 | $69.8K | $204.00 | 2.84x |
| 78608 | Nuclear medicine study brain with metabolic evaluation | 52 | $61.7K | $1.2K | 2.52x |
This provider submits charges 2.7 times higher than what Medicare actually pays.
A markup ratio of 2.7x means for every $100 Medicare pays, this provider initially charges $270. This is higher than the national average.
Always verify provider credentials and location before scheduling appointments. This data reflects Medicare payments and may not include all practice locations.
Share this provider's Medicare payment information
Last Updated: February 2026 (data through 2023, the latest CMS release)
Note: All data is from publicly available Medicare records. OpenMedicare is an independent journalism project not affiliated with CMS.
Believe this data is inaccurate? Dispute this data